Complement receptors regulate lipopolysaccharide-induced T-cell stimulation

被引:19
作者
Kaya, Z
Tretter, T
Schlichting, J
Leuschner, F
Afanasyeva, M
Katus, HA
Rose, NR
机构
[1] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany
[2] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA
关键词
T lymphocytes; lipopolysaccharide; complement; cell surface molecules; cellular activation;
D O I
10.1111/j.1365-2567.2004.02113.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement receptors type 1 and 2 (CR1 (CD35)/CR2 (CD21)) are known to enhance the adaptive immune response. In mice, CR1/CR2 are expressed on B cells, follicular dendritic cells, and activated granulocytes. Recently, we showed that a subset of CD44(high) and CD62L(low) T cells also expresses CR1 and CR2. We now report that CR1/CR2 are detectable on both CD4(+) and CD8(+) subsets of T cells. Lipopolysaccharide (LPS) from Gram-negative bacteria causes polyclonal activation of B cells and stimulation of macrophages and other antigen-presenting cells. We further demonstrate that LPS induced marked up-regulation of CD25 and CD69 on T cells from CR1/CR2 sufficient (Cr+/+), but significantly lower up-regulation on T cells from CR1/CR2 deficient (Cr-/-) mice. These findings point to a novel mechanism by which CR1/CR2 modulates the activation of T cells by LPS.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 24 条
[1]  
ARMERDING D, 1977, J IMMUNOL, V119, P1468
[2]   STUDIES ON THE EXPRESSION OF SPONTANEOUS AND INDUCED INTERFERONS IN MOUSE PERITONEAL-MACROPHAGES BY MEANS OF MONOCLONAL-ANTIBODIES TO MOUSE INTERFERONS [J].
BELARDELLI, F ;
GESSANI, S ;
PROIETTI, E ;
LOCARDI, C ;
BORGHI, P ;
WATANABE, Y ;
KAWADE, Y ;
GRESSER, I .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2203-2212
[3]   INHIBITION OF EPSTEIN-BARR VIRUS-MEDIATED CAPPING OF CD21 CR-2 BY ALPHA-INTERFERON (IFN-ALPHA) - IMMEDIATE ANTIVIRAL ACTIVITY OF IFN-ALPHA DURING THE EARLY PHASE OF INFECTION [J].
DELCAYRE, AX ;
LOTZ, M ;
LERNHARDT, W .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2918-2921
[4]   CR1(CD35) AND CR2(CD21) COMPLEMENT C3 RECEPTORS ARE EXPRESSED ON NORMAL HUMAN THYMOCYTES AND MEDIATE INFECTION OF THYMOCYTES WITH OPSONIZED HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DELIBRIAS, CC ;
MOUHOUB, A ;
FISCHER, E ;
KAZATCHKINE, MD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) :2784-2788
[5]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350
[6]  
Fang YF, 1998, J IMMUNOL, V160, P5273
[7]  
FISCHER E, 1991, J IMMUNOL, V146, P865
[8]  
GOODMAN MG, 1979, J IMMUNOL, V122, P2548
[9]   Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2 [J].
Kacani, L ;
Prodinger, WM ;
Sprinzl, GM ;
Schwendinger, MG ;
Spruth, M ;
Stoiber, H ;
Döpper, S ;
Steinhuber, S ;
Steindl, F ;
Dierich, MP .
JOURNAL OF VIROLOGY, 2000, 74 (17) :7997-8002
[10]   Contribution of the innate immune system to autoimmune myocarditis: a role for complement [J].
Kaya, Z ;
Afanasyeva, M ;
Wang, Y ;
Dohmen, KM ;
Schlichting, J ;
Tretter, T ;
Fairweather, D ;
Holers, VM ;
Rose, NR .
NATURE IMMUNOLOGY, 2001, 2 (08) :739-745